The continuing saga of complement receptor type 3 (CR3)
Todd
R F
RF
D003602:Cytotoxicity, Immunologic; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D016177:Macrophage-1 Antigen / Q000276:immunology*; D009369:Neoplasms / Q000188:drug therapy; D009504:Neutrophils / Q000276:immunology*; D011134:Polysaccharides / Q000276:immunology* / Q000494:pharmacology
D016177:Macrophage-1 Antigen; D011134:Polysaccharides